메뉴 건너뛰기
Neurology
Volumn 72, Issue 13, 2009, Pages 1116-1117
Extending MCI beyond alzheimer disease
Author keywords

[No Author keywords available]
Indexed keywords

AGING; ALZHEIMER DISEASE; COGNITION; EDITORIAL; HUMAN; MEDICAL LITERATURE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PRIORITY JOURNAL; COGNITIVE DEFECT; NOTE; PSYCHOLOGICAL ASPECT;
EID: 65249083319     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000345369.41620.fc     Document Type: Editorial
Times cited : (6)
References (8)
  • 1
    • 51249116898 scopus 로고    scopus 로고
    • Two-year progression from mild cognitive impairment to dementia: To what extent do different definitions agree?
    • Matthews FE, Stephan BC, McKeith IG, et al. Two-year progression from mild cognitive impairment to dementia: to what extent do different definitions agree? J Am Geriatr Soc 2008;56:1424-1433.
    • (2008) J Am Geriatr Soc , vol.56 , pp. 1424-1433
    • Matthews, F.E.1    Stephan, B.C.2    McKeith, I.G.3
  • 2
    • 33646437238 scopus 로고    scopus 로고
    • Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia
    • Jicha GA, Parisi JE, Dickson DW, et al. Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. Arch Neurol 2006;63:674-681.
    • (2006) Arch Neurol , vol.63 , pp. 674-681
    • Jicha, G.A.1    Parisi, J.E.2    Dickson, D.W.3
  • 3
    • 0036250657 scopus 로고    scopus 로고
    • The public health impact of Alzheimer's disease, 2000-2050: Potential implication of treatment advances
    • Sloane PD, Zimmerman S, Suchindran C, et al. The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances. Annu Rev Public Health 2002;23:213-231.
    • (2002) Annu Rev Public Health , vol.23 , pp. 213-231
    • Sloane, P.D.1    Zimmerman, S.2    Suchindran, C.3
  • 4
    • 65249115240 scopus 로고    scopus 로고
    • Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest Study
    • for the Norwegian ParkWest Study Group
    • Aarsland D, Brønnick K, Larsen JP, Tysnes OB, Alves G, for the Norwegian ParkWest Study Group. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest Study. Neurology 2009; 72:1121-1126.
    • (2009) Neurology , vol.72 , pp. 1121-1126
    • Aarsland, D.1    Brønnick, K.2    Larsen, J.P.3    Tysnes, O.B.4    Alves, G.5
  • 5
    • 35348939603 scopus 로고    scopus 로고
    • Clinical diagnostic criteria for dementia associated with Parkinson's disease
    • Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007;22:1689-1707.
    • (2007) Mov Disord , vol.22 , pp. 1689-1707
    • Emre, M.1    Aarsland, D.2    Brown, R.3
  • 6
    • 35848953181 scopus 로고    scopus 로고
    • Updated research nosology for HIV-associated neurocognitive disorders
    • Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007;69:1789-1799.
    • (2007) Neurology , vol.69 , pp. 1789-1799
    • Antinori, A.1    Arendt, G.2    Becker, J.T.3
  • 7
    • 35349009157 scopus 로고    scopus 로고
    • Modern concept of vascular cognitive impairment
    • Bowler JV. Modern concept of vascular cognitive impairment. Br Med Bull 2007;83:291-305.
    • (2007) Br Med Bull , vol.83 , pp. 291-305
    • Bowler, J.V.1
  • 8
    • 0035964234 scopus 로고    scopus 로고
    • Clinical markers of early disease in persons near onset of Huntington's disease
    • Paulsen JS, Zhao H, Stout JC, et al. Clinical markers of early disease in persons near onset of Huntington's disease. Neurology 2001;57:658-662.
    • (2001) Neurology , vol.57 , pp. 658-662
    • Paulsen, J.S.1    Zhao, H.2    Stout, J.C.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.